Beijing Zhongsheng Jinyu Diagnosis Technology Co., Ltd.
Beijing Zhongsheng Jinyu Diagnosis Technology Co., Ltd.
🇨🇳 China, Beijing Shi
2003101-200 peopleManufacturer/Trading CompanyBeijing Zhongsheng Jinyu Diagnosis Technology Co., Ltd. is a prominent high-tech enterprise based in Beijing, China, specializing in the research, development, and manufacturing of in-vitro diagnostic (IVD) and Point-of-Care Testing (POCT) solutions. Established in 2003 and supported by the Institute of Biophysics of the Chinese Academy of Sciences, the company operates as a subsidiary of the Biosino Group. It is recognized as a national high-tech enterprise and a demonstration unit for industry-research integration, having been listed on the New Third Board since 2016.
The company maintains a robust manufacturing infrastructure with six specialized POCT production lines and a workforce of approximately 100 to 200 employees. Their comprehensive product portfolio focuses on maternal and child health, nutritional assessment, and chronic disease surveillance. Key offerings include innovative diagnostic kits for bacterial vaginosis, aerobic vaginitis, bone metabolism (BAP), urinary iodine, and intestinal barrier function. Notably, their Vaginal Fluid Analysis System and various rapid-assay kits are widely utilized in over 2,000 medical institutions across China.
As an ISO 9001 and ISO 13485 certified manufacturer, Beijing Zhongsheng Jinyu Diagnosis Technology Co., Ltd. emphasizes quality and independent innovation. They provide OEM and contract manufacturing services, leveraging advanced R&D platforms in whole blood dry slice, multilayer film, and enzymatic chemical sensor technologies. Their products are designed for diverse clinical environments, ranging from hospital outpatient departments and community health centers to portable home-use testing applications.
OEM manufacturerOffers OEM services for customized brand manufacturing.
Patented technologyHolds multiple product or process patents.
Industry association memberMember of China Association of in vitro diagnostics, Clinical Nutrition Industry Strategic Alliance association.
High-tech enterpriseRecognized as a high-tech or innovative enterprise.
Contact
*******************
1
*************
3
Products
Products
0
Categories
0
Average Price
$0.00
MOQ Range
0
Vaginal Fluid Analysis System
0·0 reviews
Vaginal Fluid Analysis System, Find Details and Price about Vaginal Vaginosis Analysis System Vaginitis Test from Vaginal Fluid Analysis System - Beijing Zhongsheng Jinyu Diagnostic Technology Corporation Co., Ltd.$1000Certifications
ISO 90011
ISO 134851
Ask AI about this supplier
Shipments
Shipments count
0
Export volume
0 kg
Export countries
0
Insights
Top 5 customers
Reflecting the depth of cooperation between supplier and customersTop 5 customers
This insight is only available in the Pro planTop 5 export countries
Reflecting the supplier's export experience in target countriesTop 5 export countries
This insight is only available in the Pro planShipment count distribution
Reflecting the supplier's market business activityAll categories
Shipment count distribution
This insight is only available in the Pro planExport weight distribution (kg)
Reflecting the supplier's export scaleAll categories
Export weight distribution (kg)
This insight is only available in the Pro planExport weight trend (kg)
Reflecting the growth rate of the supplier's phased total supply volume and the fluctuation of supply volume, identifying supply peaks and troughsAll categories
Export weight trend (kg)
This insight is only available in the Pro planCIF trend (USD)
For identifying high-value cooperation periods and single order value changesAll categories
CIF trend (USD)
This insight is only available in the Pro planSimilar suppliers you may like
Beijing Mygenostics Co., Ltd.
🇨🇳 China
2011501-1000 peopleManufacturer/Service CompanyHigh capacity factory
High-tech enterprise
Patented technology
Low MOQ
Key market
Europe
Description
Beijing Mygenostics Co., Ltd. is a leading high-tech biotechnology manufacturer and service provider established in 2011. Headquartered in Beijing with a 10,000-square-meter research and medical laboratory facility, the company also operates a wholly-owned subsidiary in Chongqing. With a workforce of over 750 employees, Mygenostics specializes in the R&D, production, and marketing of molecular diagnostics products, IVD devices, and comprehensive genomic solutions. The company is recognized for its patented GenCap™ technology, which enhances next-generation sequencing (NGS) by capturing both strands of genomic target regions to improve accuracy and reduce costs.
Their extensive product portfolio includes automated liquid handlers, nucleic acid extraction systems and kits, PCR kits, and specimen collection solutions. They also provide automated pipetting systems, microplate washers, and laboratory plastics. Mygenostics serves the scientific research, clinical, and diagnostic industries, offering OEM services and technical support. The company maintains high quality standards with ISO 13485 and FSC certifications. Since 2021, they have expanded their international trade footprint, exporting to Europe, the Middle East, South America, Africa, and Southeast Asia. Their technical excellence is supported by collaborations with prestigious universities and hospitals globally, contributing to over 450 scientific research papers and conducting more than 170,000 clinical tests.
Baby Care Kit$12.99
Capitalbio Technology Co., Ltd.
🇨🇳 China
101-200 peopleManufacturer/Service CompanyHigh-tech enterprise
Low MOQ
Shipments
144
Key customer
DOIT
Key market
🇻🇳 Vietnam
Description
Capitalbio Technology Co., Ltd. is a contract manufacturer and service company based in Beijing, China, operating as the industrialization platform of the CapitalBio Corporation and the Beijing National Engineering Research Center for Biochips. Established with 101 to 200 employees, the company integrates R&D, production, sales, and third-party independent medical laboratory services. Capitalbio Technology specializes in genetic detection and microarray technology, offering products such as Ngs Mutation Detection, Cnv-Seq Detection, Capitalbio® Microarray Scanner Luxscan™ 10K/D, Capitalbio® DNA Microarray Scanner Luxscan™ 10K, and Capitalbio® Microarray Hybridization Station. They also provide comprehensive genetic testing services, including those for hereditary cancers (e.g., BRCA1/2), blood cancer, and folic acid utilization ability. The company emphasizes independent innovation and achievement transformation, aligning with national health policies by integrating modern and traditional Chinese medicine to form a broad health industry section.
Genetic Testing of 18 Hereditary Cancer$10
Forensic Platform$10
Genetic Testing for Blood Cancer$10
Genetic Testing for Brca1/2 Targeted-Drug Guidance [ Germline + Somatic]$10
Genetic Testing for Hereditary Breast/Ovarian Cancer (BRCA1/2)$10
Folic Acid Utilization Ability Genetic Detection$10
